萨罗格利塔萨尔与西姆瓦斯塔丁治疗代谢性和与酒精有关的肝病 (MetALD)
Anand Kulkarni1, Zaid M Gangdany2, Ramyashree Ramagundam2
1Hepatology, Asian Institute of Gastroenterology, Hyderabad, IND.
Cureus
|July 11, 2025
概括
与simvastatin相比,saroglitazar在代谢性和与酒精有关的肝病 (MetALD) 患者的肝脂肪 (CAP得分) 和硬度 (LSM) 中显示出更大的改善. 它还显著降低了HbA1c水平.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢障碍 代谢障碍 代谢障碍
- 药理学 药理学是指药理学的学科.
背景情况:
- 代谢和与酒精有关的肝病 (MetALD) 是一个日益增长的临床挑战.
- 目前对MetALD的治疗选择有限,需要对新型治疗剂进行研究.
- 在MetALD患者中,沙洛格利塔萨和西姆瓦斯塔丁的比较疗效尚未得到充分证实.
研究的目的:
- 在被诊断患有MetALD的患者中,比较萨罗格利塔萨尔与西姆瓦斯塔丁的疗效.
- 为了评估这些治疗对肝硬化,纤维化和心脏代谢标记物的影响.
主要方法:
- 一个单一中心的回顾性队列研究包括102名患有MetALD.的患者.
- 患者接受了沙洛格利塔萨或西姆瓦斯塔丁.
- 评估的结果包括控制减弱参数 (CAP) 评分的变化,肝硬度测量 (LSM) 和糖化血红蛋白 (HbA1c).
主要成果:
- 虽然CAP得分的降低在各组之间没有统计学意义 (P=0.08),但saroglitazar显示出更大改善的趋势.
- 与simvastatin (P=0.01) 相比,saroglitazar显著降低了肝硬度测量 (LSM) 的得分.
- 相比于simvastatin (P=0.02),萨罗格利塔萨尔显示HbA1c水平的显著降低 (P=0.02).
结论:
- 萨罗格利塔萨似乎比simvastatin更有效地改善肝硬化,减少肝硬度,并控制六个月的MetALD患者的血糖水平.
- 这些发现表明萨罗格利塔萨尔是MetALD.的潜在治疗选择.
- 建议进一步进行前性随机对照试验,以证实这些结果.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
879
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
879
Oral Hypoglycemic Agents: Biguanides and Glitazones
309
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
309
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
271
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
271
Diseases of the Liver and Gallbladder
1.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.0K
Oral Hypoglycemic Agents: Sulfonylureas
349
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
349
Cholesterol: Significance and Regulation
697
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
697


